½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸ Echo Seoul & Cardiac Imaging 2022(2ÀÏÂ÷) : 2022-10-16±³À°ÀÏÀÚ : 2022-10-16
±³À°Àå¼Ò : »ï¼º»ý¸í ÀÏ¿ø¿ªºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦
±³À°ÁÖÁ¦ :
(¿Â,¿ÀÇÁ¶óÀÎ µ¿½Ã°³ÃÖ) Echo Seoul & Cardiac Imaging 2022(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸
´ã´çÀÚ : Àå½ÅÀÌ
¿¬¶ôó : 02-3410-2754
À̸ÞÀÏ :
bautai.jang@samsung.com ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 90,000¿ø
ºñ°í Àü¹®ÀÇ, °³¿øÀÇ, °øÁߺ¸°ÇÀÇ, ±ºÀÇ°ü: ¿Â¶óÀÎ 50000 / ÇöÀå 90000 ÀüÀÓÀÇ, »ê¾÷ü, ±âŸ: ¿Â¶óÀÎ 30000 / ÇöÀå 70000 Àü°øÀÇ, ÀÎÅÏ, Sonographer, °£È£»ç, ¹æ»ç¼±»ç, ÀÓ»óº´¸®»ç, Çлý: ¿Â¶óÀÎ 20000 / ÇöÀå 70000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 08:30~08:45 Multimodality imaging-based treatment in PHV disease À̽¾Æ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 08:45~09:00 Revisit of functional TR: current trends in diagnosis Rebecca hahn(NewYork-Presbyterian/Columbia University Irving Medical Center)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:00~09:15 Treatment decision using multimodality imaging in TR ±èÀº°æ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:15~09:30 Current status and multimodality imaging of TV intervention Rebecca hahn(NewYork-Presbyterian/Columbia University Irving Medical Center)
Åä·Ð 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:30~09:50 Panel discussion ±è¼º¾Ö ¹Ú¼º¹Ì Á¤¼ö·Ã Á¤¿ì¹é(´Ù¼Ò¼Ó)
ÈÞ½Ä 10-16 9Ãþ °ÀǽÇ(¿¹,Áö) 09:50~10:00 Break ()
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:00~10:15 Multimodality imaging in MS: Echo score is enough to assess feasibility of PMV? ±èÁöÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:15~10:30 Mitral valve remodeling in functional MR Shun Nishino(Miyazaki Medical Association Hospital)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:30~10:45 Preoperative ion for successful MV repair/replacement: My Clinical practice Á¤µ¿¼·(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:45~11:00 MR and TEER: Current Status and Experience in Korea ±è´ëÈñ(¿ï»êÀÇ´ë)
Åä·Ð 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:00~11:20 Panel discussion Á¶ÀÎÁ¤ À̼ö¿¬ ±èÇü¼· À̼±È(´Ù¼Ò¼Ó)
ÈÞ½Ä 10-16 9Ãþ °ÀǽÇ(¿¹,Áö) 11:20~11:30 Break ()
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:30~11:45 A need for precision approach in AS À̽ÂÇ¥(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:45~12:00 Timing of intervention in AS °´öÇö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:00~12:15 Multidisciplinary descision making in AS ¹Ú¼ºÁö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:15~12:30 BAV : multimodality imaging-based treatment ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë)
Åä·Ð 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 12:30~12:50 Panel discussion ¹ÚÂù¼® Á¤¹ÌÇâ ÀÓ°æÈñ ¼±º´ÁÖ(´Ù¼Ò¼Ó)
½Ä»ç 10-16 9Ãþ °ÀǽÇ(ÀÇ) 12:50~14:00 Lunch time ()
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:00~14:15 Decision in a patient with Fontan Circulation : imaging guidances Yiu-fai Cheung(The University of Hong Kong)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:15~14:30 Optimal patients ion for percutaneous PVR ¼ÛÁø¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:30~14:45 Small VSD in adult : how to treat Àº¿µ¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:45~15:00 Pitfalls in the diagnosis of PFO ¼ÛÀç°ü(¿ï»êÀÇ´ë)
Åä·Ð 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:00~15:15 Panel discussion ±è°æÁø ¼Áö¿ø ±è¹Î¼± ±è°æÈñ(´Ù¼Ò¼Ó)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:15~15:30 AMC case Á¶ÇÏÇý(¿ï»êÀÇ´ë)
Åä·Ð 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:30~15:35 Comments ±è¿ëÁø ¼ÛÀç°ü ¹Ú½Â¿ì ÇÏÁ¾¿ø(´Ù¼Ò¼Ó)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:35~15:50 SMC case Àü±â³ª(¼º±Õ°üÀÇ´ë)
Åä·Ð 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:50~15:55 Comments ±è¿ëÁø ¼ÛÀç°ü ¹Ú½Â¿ì ÇÏÁ¾¿ø(´Ù¼Ò¼Ó)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:55~16:10 SNUH case ÃÖÇýÁ¤(¼¿ïÀÇ´ë)
Åä·Ð 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:10~16:15 Comments ±è¿ëÁø ¼ÛÀç°ü ¹Ú½Â¿ì ÇÏÁ¾¿ø(´Ù¼Ò¼Ó)
±³À°½Ã°£ 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:15~16:30 Severance case ÀÌÈñÁ¤(¿¬¼¼ÀÇ´ë)
Åä·Ð 10-16 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:30~16:35 Comments ±è¿ëÁø ¼ÛÀç°ü ¹Ú½Â¿ì ÇÏÁ¾¿ø(´Ù¼Ò¼Ó)